Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 3 1Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Lung Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Linseed Oil × Clear all
NCT02475330 2021-06-08

Dietary Flaxseed in NSCLC

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
33 enrolled
Thoracic

Lung Neoplasms

NCT00049309 2017-02-23

Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer

Duke University

Phase 2 Completed
161 enrolled
Genitourinary

Prostatic Neoplasms

NCT00693082 2012-11-20

Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation

Duke University

Phase 2 Terminated
4 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡